Potential for treatment benefit of small molecule CGRP receptor antagonist plus monoclonal antibody in migraine therapy

Lignende værker

• Potential for treatment benefit of small molecule CGRP receptor antagonist plus monoclonal antibody in migraine therapy
  af: Mullin, Kathleen, et al.
  Udgivet: (2020)
• Safety of Rimegepant, an Oral CGRP Receptor Antagonist, Plus CGRP Monoclonal Antibodies for Migraine
  af: Berman, Gary, et al.
  Udgivet: (2020)
• Targeted CGRP Small Molecule Antagonists for Acute Migraine Therapy
  af: Holland, Philip R., et al.
  Udgivet: (2018)
• Prevention of migraine with monoclonal antibodies against CGRP or the CGRP receptor
  af: Hans-Christoph Diener, et al.
  Udgivet: (2020-04-01)
• CGRP receptor antagonists and antibodies against CGRP and its receptor in migraine treatment
  af: Edvinsson, Lars
  Udgivet: (2015)